Key Insights

Highlights

Treatment Research

5 treatments under study, led by Remifentanil

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Withdrawn1

Clinical Trials (1)

Showing 1 of 1 trials
NCT03763305Not ApplicableWithdrawnPrimary

Comparison of Skin Sympathetic Nerve Activity According to Different Anesthetics

Showing all 1 trials

Research Network

Common Treatments

  • Remifentanil1
  • Sevoflurane1
  • Desflurane1
  • Propofol1
  • Fentanyl1

Active Sponsors

  • Seoul National University Hospital1

Top Investigators

Activity Timeline